Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 Substudy

Date
2009
Author
Tariq, M. Umer
Gibson, C. Michael
Pride, Yuri B.
Wiviott, Stephen D.
Buros, Jacqueline L.
Zorkun, Cafer
Braunwald, Eugene
Antman, Elliott M.
Metadata
Show full item record
Abstract
Background Prasugrel led to a significant reduction in ischemic cardiovascular events among patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PC]) with stent implantation compared to clopidogrel. Whether this benefit extends to patients undergoing PCI without stent implantation is unknown.
URI
http://hdl.handle.net/20.500.12627/181055
https://doi.org/10.1016/j.ahj.2009.06.021
Collections